Objectives: To present a new standardized facial fat grafting technique.
Introduction: Injectable Tissue Replacement and Regeneration (ITR2) is a new, standardized method of fat grafting.
Materials / method: In performing ITR2 the first step is to diagnose the anatomic areas and tissues where volume loss has occurred by evaluating the surface topography of the face. Step two, addresses specific anatomic losses of these different tissues, including skin, facial fat in the deep and superficial compartments, and bone. Step three, replaces these anatomic losses with injectable autogenous or allogeneic fat grafts, de-cellurized bone and cartilage sized for structural replacement of bone and deep fat losses, superficial fat replacement and dermal and epithelial replacement and regeneration.
Results: Since 2015, all fat grafting patients underwent ITR2. ITR2 was performed alone under local or intravenous sedation; with resurfacing fractional lasers; and in patients having facelift or facial rejuvenation surgery. Complications occurred in 2 patients who required transcutaneous (n=1) or tranconjunctival (n=1) fat removal for excess noted in the lower eyelids. No instance of overgrowth has been seen to date with this anatomic approach. Improvement in skin texture and thickness has been noted up to two years after treatment.
Conclusion: Injectable Tissue Replacement and Regeneration is a new standardized means of fat grafting that addresses anatomic areas of skin, fat and bone loss. As newer techniques of injectable bone and cartilage gel are developed, losses in specific tissues can be addressed with “like” tissues, ushering in new approaches in injectable tissue engineering.
Declaraciones
¿Ha recibido algún tipo de financiamiento para realizar su investigación sobre esta temática?
No
¿Ha recibido algún pago, honorario u otra compensación por su trabajo acerca de esta investigación?
No
¿Tiene vínculos financieros con alguna entidad que podría llegar a competir estrechamente con los medicamentos, materiales o instrumentos tratados en su investigación?
Si
Por favor especifique las entidades (individuo, empresa, sociedad): Lipocube- royalties, shareholder; Tulip- royalties; Millennium Medical- royalties, shareholder
¿Posee o ha solicitado una patente relacionada a los materiales, productos o instrumentos utilizados en su investigación?
Si
Por favor especificar la fecha...: Patent pending, January 28, 2019
y el estado: ITR2 is trademarked
Este trabajo no cuenta con el apoyo de ningún financiamiento directo o indirecto. El autor asume plena responsabilidad sobre el mismo.